Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|
January 1, 1997
Looking at p53: theoretical implications and methodological aspects
B Opalka, S Kasimir-Bauer
Anti-Cancer Drugs
|
August 1, 1997
Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitro
M Stahl, S Kasimir-Bauer, A Harstrick
Experimental Hematology
|
May 1, 1994
Philadelphia chromosome-positive chronic myelogenous leukemia: functional defects in circulating mature neutrophils of untreated and interferon-alpha-treated patients
S Kasimir-Bauer, H Ottinger, G Brittinger, et al.
International Journal of Oncology
|
April 17, 2002
A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)
S Kasimir-Bauer, C Oberhoff, A E Schindler, et al.
Journal of Cancer Research and Clinical Oncology
|
February 9, 2000
In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia
J K Schröder, S Kasimir-Bauer, S Seeber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy
S Kasimir-Bauer, S Mayer, P Bojko, et al.
Anticancer Research
|
May 16, 2009
Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer
P Wimberger, M Heubner, H Lindhofer, et al.
Perfusion
|
May 4, 2001
Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter
N R Frühauf, O Dumpich, C P Kaudel, et al.
Leukemia Research
|
April 28, 2000
Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia
J K Schröder, S Kolkenbrock, J Tins, et al.
Breast Cancer Research and Treatment
|
January 5, 2002
Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?
S Kasimir-Bauer, C Oberhoff, K Sliwinska, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|
January 1, 1997
Looking at p53: theoretical implications and methodological aspects
B Opalka, S Kasimir-Bauer
Anti-Cancer Drugs
|
August 1, 1997
Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitro
M Stahl, S Kasimir-Bauer, A Harstrick
Experimental Hematology
|
May 1, 1994
Philadelphia chromosome-positive chronic myelogenous leukemia: functional defects in circulating mature neutrophils of untreated and interferon-alpha-treated patients
S Kasimir-Bauer, H Ottinger, G Brittinger, et al.
International Journal of Oncology
|
April 17, 2002
A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)
S Kasimir-Bauer, C Oberhoff, A E Schindler, et al.
Journal of Cancer Research and Clinical Oncology
|
February 9, 2000
In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia
J K Schröder, S Kasimir-Bauer, S Seeber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy
S Kasimir-Bauer, S Mayer, P Bojko, et al.
Anticancer Research
|
May 16, 2009
Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer
P Wimberger, M Heubner, H Lindhofer, et al.
Perfusion
|
May 4, 2001
Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter
N R Frühauf, O Dumpich, C P Kaudel, et al.
Leukemia Research
|
April 28, 2000
Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia
J K Schröder, S Kolkenbrock, J Tins, et al.
Breast Cancer Research and Treatment
|
January 5, 2002
Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?
S Kasimir-Bauer, C Oberhoff, K Sliwinska, et al.
Page
of 2